Clinical outcome of colposcopy guided biopsy in women with abnormal Pap smear results
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250188Keywords:
Pap smear, Colposcopy, HPV, Early detection, Screening methods, Cervical lesionsAbstract
Background: Cervical cancer is the fourth most common cancer among women globally and remains a significant public health challenge despite being largely preventable. Persistent infection with high-risk human papillomavirus (HPV), particularly HPV-16 and HPV-18, is the primary cause. Early detection through effective screening methods, such as Pap smear and colposcopy, plays a critical role in reducing cervical cancer incidence. This study evaluates the clinical outcomes of colposcopy-guided biopsy in women with abnormal Pap smear results, highlighting the importance of integrated screening approaches.
Methods: This prospective observational study was conducted in the department of obstetrics and gynaecology, GS medical college and hospital, Hapur, over 15-18 months (November 2022-February 2024). A total of 150 women aged 25-65 years with abnormal Pap smear results and cervical symptoms (e.g., leukorrhea, postcoital bleeding, intermenstrual bleeding) were included. Colposcopy-guided biopsies were performed on these patients. Data were analysed using IBM SPSS version 27, applying statistical tests like the T-test and chi-square test, with p<0.05 considered significant. Descriptive statistics summarized the data, presented in charts and tables.
Results: Among the 150 participants, 10.6% had abnormal Pap smear findings, and 17.3% had abnormal colposcopy findings. Squamous metaplasia (46.15%) and high-grade lesions (34.61%) were the most frequently observed abnormalities during colposcopy, while Pap smears predominantly revealed ASC-US (56.25%) and HSIL (31.25%). Postcoital and postmenopausal bleeding had the highest rates of abnormal findings. Colposcopy demonstrated greater sensitivity compared to Pap smear in detecting cervical lesions, emphasizing its importance in early diagnosis.
Conclusions: Colposcopy is more sensitive than Pap smear in detecting cervical abnormalities, particularly high-grade lesions. Combining these methods enhances the accuracy and reliability of cervical cancer detection. Integrating molecular tests and visual inspection techniques into existing screening protocols could further improve outcomes. Raising public awareness about regular screening, HPV vaccination, and early detection is essential to reducing cervical cancer burden globally.
Metrics
References
Balasubramaniam SD, Balakrishnan V, Oon CE, Kaur G. Key Molecular Events in Cervical Cancer Development. Med Kaunas Lith. 2019;55(7):384. DOI: https://doi.org/10.3390/medicina55070384
Momenimovahed Z, Salehiniya H. Incidence, mortality and risk factors of cervical cancer in the world. Biomed Res Ther. 2017;4(12):1795. DOI: https://doi.org/10.15419/bmrat.v4i12.386
Ono A, Koshiyama M, Seki K, Oowaki M, Nakagawa M, Ikuta E, et al. The Preventive Effect of Dietary Antioxidants on Cervical Cancer Development. Medicina (Mex). 2020;56(11):604. DOI: https://doi.org/10.3390/medicina56110604
Mendoza‑Almanza G, Esparza‑Ibarra E, Rivas‑Santiago C, Olmos J, Rocha‑Zavaleta L, OrtZ‑S, et al. Cervical cancer stem cells and other leading factors associated with cervical cancer development. Oncol Lett. 2019;18:4. DOI: https://doi.org/10.3892/ol.2019.10718
Waller J, Mccaffery K, Wardle J. Beliefs about the risk factors for cervical cancer in a British population sample. Prev Med. 2004;38(6):745-53. DOI: https://doi.org/10.1016/j.ypmed.2004.01.003
Al-Darwish AA, Morsi MS, Al-Naim AF, Aleem AM, Al-Mulhim KS, Al-Otaibi NK. Knowledge about cervical cancer early warning signs and symptoms, risk factors and vaccination among students at a medical school in Al-Ahsa, Kingdom of Saudi Arabia. Asian Pac J Cancer Prev. 2014;15(6):2529-32. DOI: https://doi.org/10.7314/APJCP.2014.15.6.2529
Zhang S, Qiao Y, Zhang L, Xu H. Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2020;32(6):720-8. DOI: https://doi.org/10.21147/j.issn.1000-9604.2020.06.05
Karimi-Zarchi M, Yazdian-Anari P, Shafii A, Zanbagh L, Shokouh T-Z, Teimoori S. Comparison of Pap Smear and Colposcopy in Screening for Cervical Cancer in Patients with Secondary Immunodeficiency. Electron Physician. 2015;7(7):1542-8. DOI: https://doi.org/10.19082/1542
Longatto-Filho A, Branca M, Derchain SF, Tatti S, Syrjänen K, Eržen M, et al. Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology. Virchows Arch. 2012;460(6):577-85. DOI: https://doi.org/10.1007/s00428-012-1242-y
Owens CL, Gustafson KS, Burroughs FH, Moats DR. Low-Grade Squamous Intraepithelial Lesion, Cannot Exclude High-Grade Squamous Intraepithelial Lesion Is a Distinct Cytologic Category. Am J Clin Pathol 2007;128(3):398-403. DOI: https://doi.org/10.1309/QRDNMWWAKJQTVJGF
Ghosh I, Mittal S, Banerjee D, Singh P, Dasgupta S, Chatterjee S, et al. Study of accuracy of colposcopy in VIA and HPV detection-based cervical cancer screening program. Aust N Z J Obstet Gynaecol 2014;54(6):570-5. DOI: https://doi.org/10.1111/ajo.12282
Shidham VB, Narayan R, Kumar N, Brotzman GL. Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePathTM specimens with review of literature. Cyto J. 2007;4(1):7. DOI: https://doi.org/10.1186/1742-6413-4-7
Morency EG, Harbert T, Maniar KP, Nayar R, Samolcyzk J, Fatima N. Anal Cytology: Institutional Statistics, Correlation with Histology, and Development of Multidisciplinary Screening Program With Review of the Current Literature. Arch Pathol Amp Lab Med. 2018;143(1):23-9. DOI: https://doi.org/10.5858/arpa.2017-0242-RA
Sherwani R, Zeba A, Khan T, Afsan N, Akhtar K, Rahman K, et al. Conventional Pap smear and liquid based cytology for cervical cancer screening-a comparative study. J Cytol. 2007;24(4):167. DOI: https://doi.org/10.4103/0970-9371.41888
Najib FS, Poordast T, Askary E, Shiravani Z, Hashemi M, Sharifi S. Diagnostic Accuracy of Cervical Pap Smear and Colposcopy in Detecting Premalignant and Malignant Lesions of Cervix. Indian J Surg Oncol. 2020;11(3):453-8. DOI: https://doi.org/10.1007/s13193-020-01118-2
Pretorius R, Semrad N, Watring W, Fotheringham N. Presentation of cervical cancer. Gynecol Oncol. 1991;42(1):48-53. DOI: https://doi.org/10.1016/0090-8258(91)90229-X
Massad LS, Collins YC, Meyer PM. Biopsy Correlates of Abnormal Cervical Cytology Classified Using the Bethesda System. Gynecol Oncol. 2001;82(3):516-22. DOI: https://doi.org/10.1006/gyno.2001.6323
Del Priore G, Maag T, Bhattacharya M, Garcia PM, Till M, Lurain JR. The Value of Cervical Cytology in HIV-Infected Women. Gynecol Oncol. 1995;56(3):395-8. DOI: https://doi.org/10.1006/gyno.1995.1069
Downloads
Published
How to Cite
Issue
Section
